Using mouse glioma models which enable the differentiation of genetically labelled MDM (Ccr2 RFP) and MG (Cx3cr1 GFP), they showed that microglia associated tumor cells increase tumor cell phagocytosis in response to CD47/SIRPA axis inhibition (226). This evidence concerns the gene CCR2 and neoplasm.